207 related articles for article (PubMed ID: 26367866)
1. MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies.
Zeng Y; Zhang Q; Zhang Y; Lu M; Liu Y; Zheng T; Feng S; Hao M; Shi H
PLoS One; 2015; 10(9):e0138049. PubMed ID: 26367866
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
3. Mucin Expression in Colorectal Cancer (CRC): Systematic Review and Meta-Analysis.
Niv Y; Rokkas T
J Clin Gastroenterol; 2019 Jul; 53(6):434-440. PubMed ID: 29782466
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas.
Jang KT; Chae SW; Sohn JH; Park HR; Shin HS
J Korean Med Sci; 2002 Feb; 17(1):29-33. PubMed ID: 11850585
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Liu T; Yin L; Li C; Wang L
Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer.
Kimura T; Tanaka S; Haruma K; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Int J Oncol; 2000 Jan; 16(1):55-64. PubMed ID: 10601549
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
11. High expression of sLex associated with poor survival in Argentinian colorectal cancer patients.
Zwenger A; Rabassa M; Demichelis S; Grossman G; Segal-Eiras A; Croce MV
Int J Biol Markers; 2014 Mar; 29(1):e30-9. PubMed ID: 24425323
[TBL] [Abstract][Full Text] [Related]
12. MUC1 and colorectal cancer pathophysiology considerations.
Niv Y
World J Gastroenterol; 2008 Apr; 14(14):2139-41. PubMed ID: 18407586
[TBL] [Abstract][Full Text] [Related]
13. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis.
Zhang Y; He S; Yu L; Shi C; Zhang Y; Tang S
BMC Cancer; 2023 Oct; 23(1):1024. PubMed ID: 37875821
[TBL] [Abstract][Full Text] [Related]
15. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Beclin-1 expression in colorectal cancer: a meta-analysis.
Han Y; Xue XF; Shen HG; Guo XB; Wang X; Yuan B; Guo XP; Kuang YT; Zhi QM; Zhao H
Asian Pac J Cancer Prev; 2014; 15(11):4583-7. PubMed ID: 24969889
[TBL] [Abstract][Full Text] [Related]
19. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
[TBL] [Abstract][Full Text] [Related]
20. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
